ICU Medical Sustainability Profile
ICU Medical, Inc., headquartered in the United States, is a leading player in the medical device industry, specialising in innovative infusion therapy and critical care solutions. Founded in 1984, the company has achieved significant milestones, including the development of advanced safety systems that enhance patient care and reduce the risk of medication errors. With a strong presence in North America and expanding operations globally, ICU Medical offers a diverse range of products, including infusion pumps, IV solutions, and customisable software. Their unique focus on integrating technology with clinical practice sets them apart in the market. Recognised for their commitment to quality and safety, ICU Medical has garnered numerous accolades, solidifying their position as a trusted partner in healthcare.
DitchCarbon Score
How does ICU Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ICU Medical's score of 34 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ICU Medical's reported carbon emissions
In 2023, ICU Medical reported total carbon emissions of approximately 44,110 kg CO2e, comprising 420 kg CO2e from Scope 1, 710 kg CO2e from Scope 2, and a significant 41,980 kg CO2e from Scope 3 emissions. Notably, the Scope 3 emissions included 20,720 kg CO2e from business travel and 20,780 kg CO2e from downstream transportation and distribution. ICU Medical is committed to achieving Net Zero emissions by 2050 in the United Kingdom. The company has set a target to reduce its Scope 3 emissions by 25% by 2030, using 2022 as the baseline year. This commitment reflects a strategic approach to addressing its carbon footprint across all scopes of emissions, aligning with industry standards for climate action. The emissions data is not cascaded from any parent organization, indicating that these figures are specific to ICU Medical's operations.
How Carbon Intensive is ICU Medical's Industry?
How Carbon Intensive is ICU Medical's Location?
ICU Medical's Scope 3 Categories Breakdown
Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 49% of Scope 3 emissions.
Top Scope 3 Categories
ICU Medical's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ICU Medical has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
